← Insider buys
VIR

Vir Biotechnology, Inc. · Healthcare

Director George A Scangos sold $284K of Vir Biotechnology, Inc.

Sold$283,771
$10.23Price
27,750Shares
−1%Stake

What VIR did after the filing

Filed Feb 20Copier in Feb 21
The stock from Wed, Feb 21 open, $9.90
−4.3%
S&P 500, same days
+3.9%

Measured over 30 trading days, to the Apr 4 close.

Traded Fri, Feb 16. Filed Tue, Feb 20, 4:02 PM ET, after the close. Returns use the Feb 21 open and the Apr 4 close. Not investment advice.